Lee, H.; Hwang, Y.; Mulder, E.J.; Song, Y.; Choi, C.; Rong, L.; Azar, D.T.; Han, K.-Y.
Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics. Int. J. Mol. Sci. 2025, 26, 9401.
https://doi.org/10.3390/ijms26199401
AMA Style
Lee H, Hwang Y, Mulder EJ, Song Y, Choi C, Rong L, Azar DT, Han K-Y.
Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics. International Journal of Molecular Sciences. 2025; 26(19):9401.
https://doi.org/10.3390/ijms26199401
Chicago/Turabian Style
Lee, Hyun, Yunjeong Hwang, Elizabeth J. Mulder, Yuri Song, Calista Choi, Lijun Rong, Dimitri T. Azar, and Kyu-Yeon Han.
2025. "Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics" International Journal of Molecular Sciences 26, no. 19: 9401.
https://doi.org/10.3390/ijms26199401
APA Style
Lee, H., Hwang, Y., Mulder, E. J., Song, Y., Choi, C., Rong, L., Azar, D. T., & Han, K.-Y.
(2025). Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics. International Journal of Molecular Sciences, 26(19), 9401.
https://doi.org/10.3390/ijms26199401
